Budding veterinary impresario Noel Fitzpatrick has announced the dates for the inaugural VET Festival, an outdoor summer event for the profession which will combine world-class CPD with family entertainment and an evening rock concert headlined by Mike Rutherford of Genesis fame.
The VET Festival, sponsored by NVSL and Natural Instinct, will take place in the grounds of the University of Surrey on Saturday 5th and Sunday 6th September 2015.
In a complete departure from the way CPD is usually delivered, lectures will take place in a 1000-seat main theatre marquee in the middle of the university campus, surrounded by smaller breakout tents, exhibitors, family entertainment and 'street food'.
Noel said: "The simple goal of The VET Festival is to provide education which is both cutting-edge and relevant to the day-to-day clinical work of vets, vet nurses and veterinary professionals in companion animal practice. But we also seek to make education fun - like going to a movie - something you can treasure, enjoy and then readily employ in clinical practice.
"There are four lecture strands: orthopaedics, oncology and soft tissue surgery, neurology, and veterinary nursing. Ten education themes will be delivered by world-class lecturers with significant experience in clinical veterinary practice. We will present this education on an innovative platform combining a fun festival atmosphere with dynamic delivery. We aim to provide real value for money, with tickets priced very affordably for a packed educational program which can also form part of the 35 CPD points needed throughout the year."
In addition to Noel himself, speakers at the event (pictured below), include: Will Eward (Assistant Professor of Orthopaedic Surgery Duke University), Nick Bacon (Head of Surgical Oncology, Fitzpatrick Referrals), Julia Tomlinson (Diplomate, American College of Veterinary Sports Medicine and Rehabilitation Twin Cities Animal Rehabilitation and Sports Medicine Clinic), Duncan Lascelles (Professor of Surgery and Pain Management at North Carolina State University College of Veterinary Medicine), Ian G Holsworth (Director VetSurg Small Animal Hospital, Ventura, California), Nick Jeffrey (Professor, Neurology and Neurosurgery College of Veterinary Medicine, Iowa State University), Laurent Findji (Senior Surgeon Soft Tissue and Oncology, Fitzpatrick Referrals) and Jolle Kirpensteijn (Chief Professional Relation Officer, Hill's Pet Nutrition).
And if that wasn't enough, there'll be an evening concert on the Saturday headlined by Mike and the Mechanics. The ONE LIVE concert is being held to promote "One Life One Medicine": the belief that we all only have one life and that there should be a symbiosis of effort to move animal and human medicine forward together. It's in support of The Humanimal Trust, the UK's first charity to further the principles of One Medicine and with the aim of progressing clinically relevant healthcare initiatives for both animals and humans at the same time.
Mike Rutherford said: "I am a huge supporter of 'One Life - One Medicine' - combining animal and human health is an important way forward and I'm looking forward to playing at the Festival, as are the rest of the Mechanics! It will be a fantastic week end - not to be missed!"
As a media partner for the event, VetSurgeon.org will be offering members a special discount, more details to be announced in due course. Publishing Editor Arlo Guthrie said: "Sounds like it should be a lot of fun, and could be a great opportunity for some of our members to meet up and have a pint or two."
All VetSurgeon members can have a 10% discount on the ticket price, by visiting the following link and entering the code VFVSURGEON10
http://www.eventbrite.co.uk/e/the-vet-festival-2015-tickets-16256763417?aff=VFVSURGEON10
For more information about the VET Festival visit: www.vetfestival.co.uk
Enrobactin contains enrofloxacin but is uniquely available in 10ml bottles for convenient dispensing in practice.
Enrobactin can be used to treat digestive, respiratory tract and skin and wound infections and features a distinctive caramel aroma.
Madeline Haynes, Product Manager, said: "Offering practices solutions which are efficacious but also easy to use is a key focus at Virbac, particularly given the importance in practice of using antibiotics responsibly and accurately across all species. Enrobactin is a good example of this and we are pleased to launch it."
As part of the campaign, veterinary practices are being urged to measure their feline patients’ blood pressure from seven years of age and above, as recommended by ISFM (International Society of Feline Medicine) 1.
Ceva says it will also continue the Mercury Challenge, its study of feline blood pressure, throughout 2019 to help increase veterinary professionals' confidence in measuring blood pressure and identifying feline hypertension.
The company says that since June last year, 128 practices and over 1,000 cats have participated in the challenge. You can registered to take part at: mercurychallenge.ceva.com, where there's a chance to win diagnostic tools to help diagnose feline hypertension.
Dr Rosanne Jepson, American, European and RCVS Specialist in Small Animal Internal Medicine at the Royal Veterinary College, said: "It is great to see that so many cats (over 1000!) and practices in the UK have been involved with the Mercury Challenge promoting the measurement of blood pressure and detection of hypertension.
"I would urge as many practices as possible to measure blood pressure; it’s simple, quick and easy to perform and means that we can help prevent target organ damage which at its most severe can leave cats sadly blind for the rest of their life. With careful identification and treatment this can so easily be prevented."
To help raise awareness of Feline Hypertension Month, Ceva has produced a range of marketing materials including waiting room displays, a pet owner leaflet and veterinary marketing packs, which are available upon request.
The initiative will be supported with an extensive PR campaign aimed at pet owners, including a radio day starring CBBC’s Rory the Vet.
For more information, contact cevauk@ceva.com or visit mercurychallenge.ceva.com.
References
Bonqat 50 mg/ml oral solution for cats contains pregabalin, an analgesic, anti-epileptic which has now been licensed for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats.
Tessie 0.3 mg/ml oral solution for dogs contains tasipimidine and is licensed for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure.
Dômes Pharma points to research which shows that in the UK 1.4 million1 dogs show signs of distress when left alone, and 4.4 million dogs1 show fear of loud noises.
In addition, over 4 million cats2 are not having routine vet checkups each year, with 26%2 of these owners reporting that it is too stressful for their cat or themselves.
Jonathan Hill, UK country manager at Dômes Pharma sid: "Dômes Pharma is excited to be launching two new innovative products to help vets manage cases in this complex area.
"These products expand our portfolio and provide essential options for owners and their pets struggling with these situational related problems."
https://www.tvm-uk.com/the-behavioural-range
Reference
Concern has been expressed in the profession about environmental contamination from products used in companion animal treatment for ectoparasites, such as fleas and ticks.
In recent years there has been a widely documented fall in the abundance of many terrestrial invertebrate populations1.
While the decline has been mostly linked to agricultural chemicals, there is a concern that companion animal ectoparasiticides could also be a contributing factor, with a recent study2 confirming the presence of common compounds used in flea-treatment3 in UK waterways.
However, the association with companion animal ectoparasiticides is currently poorly understood, with a significant knowledge gap and little robust research available to assess the true importance and environmental consequences.
The funded project ‘Assessing the Environmental Risk from Ectoparasite Treatments in Companion Animals’ will be led by Professor Richard Wall, Professor of Zoology and Dr Emily Bell, Senior Lecturer at University of Bristol in collaboration with Dr Imogen Schofield, Veterinary Statistician and Epidemiologist at CVS, and Lizzie McLennan-Green, Small Animal Veterinary Director at CVS.
It will be conducted via a PhD studentship at the University of Bristol as part of the CVS Clinical Research Awards.
The research will include a longitudinal ‘citizen science’ study with pet owners to develop a greater understanding of owner use and attitudes towards ectoparasiticides.
It will also include laboratory assessments of ectoparasiticide residues collected from companion animals to provide evidence-based information on the potential environmental impact of the treatments when applied to companion animals.
It is hoped the study will help the wider veterinary profession develop the most appropriate approaches to prescribing and use of ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’. The study is also set to benefit companion animals, as the research will inform strategies to ensure the most appropriate control of parasitic burden to pets.
The project starts in January 2023 and will run for three-years as a full time PhD.
CVS is providing £95,000 to fund the research.
Elanco Animal Health has announced that there have been extensions to the withdrawal periods for Dectomax (doramectin) 10 mg/ml Solution for Injection and Micotil (tilmicosin) 300 mg/ml Solution for Injection.
For Dectomax injectable, meat withdrawal for cattle and sheep will be extended to 70 days and pigs to 77 days. For Micotil, sheep milk withdrawal will be extended to 18 days and milk from cows during the dry period or from pregnant heifers should not be used for human consumption until 36 days after calving.
Elanco is reminding veterinary surgeons and SQPs that they may continue to prescribe according to the current label but it is good practice to implement revised withdrawal periods. The company is also taking this opportunity to highlight the importance of getting into the habit of double-checking withdrawal periods when administering drugs, because they do change from time to time in the light of new knowledge.
Lizzie joined the College as Head of Communications in February 2005, in which role she oversaw the launch of the Practice Standards Scheme in 2006, an overhaul of the College’s design and branding in 2011 and the joint British Veterinary Association Vet Futures project in 2014. More recently, she has been the driving force behind the Mind Matters mental health initiative.
Lizzie was appointed as Director of Strategic Communications in November 2015 and Deputy CEO in September 2016. She became Acting CEO when Nick Stace left the position of CEO at the end of September 2017.
The College advertised the position in the Sunday Times online for four weeks, and used a recruitment agency called Saxton Bampfylde. In all, 60 candidates applied.
RCVS President Professor Stephen May said: "This was a very rigorous recruitment process with a very strong field of candidates and so it is a testament to Lizzie’s abilities and achievements that she saw off all the opposition.
"For some time Lizzie has been involved in setting the direction of the College through the Strategic Plan and the initiatives and projects that she has managed, which really have had a very tangible impact on the profession.
"For example, the Vet Futures project has encouraged the profession to think more strategically about the issues that are facing it and how to achieve constructive solutions, while the Mind Matters Initiative has helped get veterinary mental health further up the agenda and reduced the stigma that many feel about it.
"Her drive and her passion has really pushed these projects forward and I believe she will bring this to the role of CEO.”
Lizzie said: "I am delighted and feel honoured to have been chosen to take the College forward into its next stage of development. I see the Council’s choice of an internal candidate, able to maintain momentum for change and help the College continue on our current strategic path, as an endorsement of the amazing work of the staff at Belgravia House.
"Under Nick Stace’s leadership, the College achieved some really excellent things for the profession, the public, and animal health and welfare, and I look forward to our next exciting chapter."
The first charge related to his conviction on two counts of common assault by beating two individuals at an incident in December 2016, as a result of which he was made subject to a community order and a restraining order, as well as being fined and made to pay a victim surcharge and costs.
The second charge related to him undertaking, or attempting to undertake non-emergency surgery on the eyelid of one of the individuals referred to in the first charge, and administering, or attempting to administer, a Prescription-Only Veterinary Medicines to the same person.
The third charged related to an allegation that he had supplied the same individual with a Prescription-Only Medication other than in accordance with a valid prescription.
The second charge and third charges related to incidents which occurred some considerable time before the assault, not as a consequence of it.
At the outset of the hearing Mr Sutcliffe admitted the first and second charges against him and that these constituted serious professional misconduct. He denied the third charge. In relation to that charge the Committee found that, having considered the totality of the evidence, it was unable to be sure that the College had proved the allegation to the requisite standard of proof, namely so that the Committee was sure. Accordingly Charge 3 was dismissed.
The Committee decided that the convictions in the first charge rendered Mr Sutcliffe unfit to practise veterinary surgery and that his conduct in Charge 2 constituted serious professional misconduct.
The Committee then went on to consider sanction.
The Committee considered the aggravating features for both charges. For the first charge it considered the actual injury to one of his victims and risk of injury to the other, noting also that both of his victims were vulnerable people and one was a child, and that the overall incident during which the assaults occurred lasted over a seven hour period.
For the second charge, aggravating factors were that the non-emergency surgery performed by Mr Sutcliffe was wholly inappropriate, that there was a risk of injury to the individual on whom he performed the surgery and that his conduct was reckless.
The mitigating factors considered by the Committee were that Mr Sutcliffe recognised the gravity of the findings against him and demonstrated insight into the allegations, that the incident in charge 1, though prolonged, was an isolated one, that the incident in charge 2 was consensual and did not result in actual harm and that neither charge had any connection with Mr Sutcliffe’s veterinary practice, nor did they affect client care or animal welfare.
Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "As recognised by the Committee, the respondent has displayed insight as to the seriousness of his behaviour. Having regard to the evidence of all the character witnesses and the written testimonials the Committee accepts that the respondent’s conduct as set out in charges 1 and 2 was wholly out of character and, therefore, there is no significant risk of repeat behaviour. The Committee considers that the respondent would be fit to return to practise, having regard to his excellent track record as a veterinary surgeon to date, after any period of suspension.
"Having regards to the aggravating and mitigating factors in this case, the Committee has decided that it is sufficient to maintain public confidence in the profession and declare and uphold proper standards of conduct to give a direction for suspension of the respondent’s name from the Register of Veterinary Surgeons.
"The Committee considers that the period of suspension must be sufficient to mark the seriousness of the charges but must be proportionate and fair in the circumstances of the case. The Committee has therefore concluded that the appropriate period of suspension is six months."
Mr Sutcliffe has 28 days from being informed of the Committee’s decision to appeal to the Privy Council.
In a separate statement, Mr Stevens said: "Anything that gives homeopathy a veneer of credibility risks chancers being able to con more people into parting with their hard-earned cash in return for bogus treatments which at best do nothing, and at worst can be potentially dangerous."
One of the dangers Mr Stevens referred to was the "rise in misinformation about vaccines - some of which is apparently promoted by homeopaths - and which poses a significant danger to human health."
In other words, anyone gullible enough to believe that a dilution of 1,000,000,000,000 parts of water to one part of crude oil, or skimmed milk, or human placenta, or condoms, or anything else for that matter, is going to cure them of anything, is more likely to believe all sorts of anti-vaccine, anti-pharmaceutical company nonsense, something which is very dangerous at a time when vaccination rates have been declining.
Human medicine does not have the monopoly on nonsense, of course. There are those who continue to peddle the lie that homeopathy can cure cancer in animals, and as the declining rates of human vaccination would tend to suggest, no shortage of people prepared to believe them.
Niall Taylor MRCVS, author of No Way To Treat a Friend, said: "The situation in the veterinary profession mirrors that in the medical profession: a small number of people preaching the benefits of a discredited belief system to vulnerable people.
"Some in the profession argue that we should humour those owners who practise homeopathy in animals, as to challenge them would drive them underground. The problem is that if we don't challenge them, we help foster a belief system which doesn't just harm animal health, but human health too. So the skill here is to find ways to challenge these beliefs in a way that is empathetic and constructive."
The grant has been awarded to Dr Carri Westgarth, a Lecturer in Human-Animal Interaction at the University of Liverpool, for her project entitled Using citizen science to develop a ‘Canine Ageing and Wellbeing’ tool for use in veterinary practice.
Dr Westgarth’s initiative aims to determine what senior dog preventative healthcare and treatment advice is currently offered in UK veterinary practices and then take steps to build a practical tool to facilitate knowledge-sharing between owners and veterinary professionals.
Carri said: "Dogs are living up to twice as long as they did 40 years ago and there are implications for senior dogs’ healthcare and wellbeing.
"As life expectancy increases, so does the amount of time spent in poor health. Many dog owners may not be aware of the signs of serious age-related diseases as they attribute them to normal age-related changes."
The Citizen Science project will investigate owner expectations, experiences and attitudes to ageing in dogs, including preventative care and general understanding of normal and abnormal changes during ageing.
A number of in-depth interviews and questionnaire surveys with veterinary professionals and dog owners will be conducted, and pet owners will be invited to submit diaries, photographs or videos to share their experiences of living with an older dog. The study will also examine electronic health records of senior dogs reported in the Small Animal Veterinary Surveillance Network.
The findings will be used to develop the Petsavers Canine Ageing and Wellbeing tool, to guide on best practice discussions in consultations with senior dogs.
Vetoquinol UK Limited has launched Kefloril, containing 300mg/ml florfenicol for use in cattle and pigs in 100ml and 250ml vials.
In cattle, Kefloril is licensed for preventative and therapeutic treatment of respiratory tract infections. In pigs, Kefloril is licensed for the treatment of acute outbreaks of respiratory disease. Kefloril has the added benefit of traceability stickers which are attached to each vial, designed to make it easier and quicker to record and monitor on-farm usage.
Vetoquinol says the addition of Kefloril to its anti-infective domain provides a cost-effective treatment for respiratory cases this winter.
The £35 course is aimed at veterinary surgeons, veterinary nurses, receptionists and practice managers who may be faced with difficult and sensitive conversations around pet loss with clients. It covers:
Empathy vs sympathy
Communicating with active listening skills
Open questions
Face-to-face emotional support, telephone support, email support and other written communication
The Blue Cross says that the new course complements its £280, eight-week 'Pet Bereavement Support' course for more in-depth training, and also its hourly webinars, which cost £20.
The eight-week course requires a minimum of three to four hours of study per week and counts towards 32 hours Continual Professional Development.
For specific needs, the Blue Cross can also work with practices to provide bespoke face-to-face training across the UK, specifically tailored and delivered at the practice.
For more information, visit www.bluecross.org.uk/pbss-course or call 01993 867216.
The College says the speed and accuracy of scans produced by the new scanner will revolutionise the treatment of animals at the Queen Mother Hospital for Animals (QMHA). It also reduces the need for animals to be anaesthetised before being scanned, with most patients now only requiring partial sedation.
The new scanner has been named the 'Otter Scanner' after a patient of the RVC whose owner was made a significant donation towards the RVC's charity, the Animal Care Trust, which funded the new machine.
Professor Dan Chan, Professor of Emergency and Critical Care Medicine and Medical Director of the QMHA at the RVC, said: "It is very uncommon that such an incredible leap in the care of animals can be achieved with a single innovation.
"Because of the vast improvement in speed and quality of the images produced by the ‘Otter Scanner’ our specialists are now able to obtain much more detailed images of various diseases affecting our patients so that the best possible treatment can be planned.
"At the RVC, one of our most important missions is to always improve the welfare and care of animals and this latest innovation is just another example of that commitment. We are forever grateful to all our supporters who have made this possible."
The survey, which received 2445 responses from BVA members, found that 16% of vets and vet students have personally experienced discrimination within a veterinary workplace or learning environment in the past twelve months, while 20% had witnessed discrimination.
Senior colleagues were most commonly responsible for the discrimination (47% of incidents), with discrimination from clients accounting for 35% of incidents.
Sex discrimination was the most common type reported (44% of incidents) and was particularly prevalent in academic settings and in production animal, equine, and mixed practices.
Race discrimination was the next most commonly reported (27% of incidents).
Respondents also gave details of discrimination in relation to other protected characteristics, including age, sexuality, disability and gender reassignment.
Younger vets were more likely than older vets to have personally experienced discrimination in the past year (27% of those under 35 had experienced discrimination).
Female vets were more than twice as likely to have experienced discrimination than their male colleagues (19% and 8% respectively).
The incidence of discrimination was higher amongst vets from a range of minority ethnic backgrounds. Those who described their sexual orientation as bi, gay or lesbian were twice as likely to have personally experienced discrimination in the past year.
Despite the high incidence of discrimination reported, responses to the same survey showed that only 56% of the profession feel concerned about discrimination.
British Veterinary Association Junior Vice President Daniella Dos Santos (pictured right) said: "This is the first time anyone has collected such a significant body of evidence on this issue and the results are truly shocking. It is completely unacceptable that so many members of the veterinary team are subject to discrimination not just from clients but from members of our own profession.
"Worryingly, it seems that the scale of the issue will come as a surprise to many members of our profession and so it is vital that we all join the conversation and reflect on what role we can play to improve equality and inclusion. The veterinary team must become a safe and supportive environment for everyone. We cannot accept anything less for ourselves, for our colleagues and for our profession."
Only 12% of respondents were satisfied with how their incident had been dealt, rising to 23% among those who felt able to report. Daniella said: "Many of the experiences documented in our report are shocking and distressing and this distress is often compounded by what comes next. It was very saddening to hear that so many people have felt unable to report their experiences or that their reports were handled badly by those who received them.
"Experiencing discrimination can be very traumatic, without the ‘double-whammy’ of having your complaint dismissed or mishandled by managers or senior staff. We need to make sure everyone who experiences discrimination is able to get the outcome they deserve.
"Through the discrimination questionnaire we heard many distressing stories from vets, students, vet nurses and other colleagues. We are incredibly grateful to them for sharing these with us so that we can raise awareness of what’s happening in our veterinary workplaces."
To raise awareness of the scale of the issue, the BVA is inviting all members of the veterinary team to join a "Big Conversation on equality and inclusion in the veterinary professions", starting with the release of its report on the current situation on discrimination, which can be downloaded here, then inviting everyone to join online engagement sessions through social media and BVA members to feed in views via their regional representatives ahead of Council on 24 July.
The association has also compiled free access special collection on backyard poultry in the BSAVA library which is available until the end of December 2019.
The BSAVA's Q&As on avian influenza in backyard poultry are:
What is avian influenza?Avian influenza (AI) is highly contagious viral disease that affects both domestic and wild birds. AI viruses are usually classified into two categories: low pathogenicity avian influenza (LPAI), which typically causes no or very few clinical signs in poultry, and high pathogenicity avian influenza (HPAI) which typically causes high mortality rates in poultry1.
What are the clinical signs of disease in poultry?The type and severity of clinical signs displayed will be dependent upon the strain of the virus and the species affected; some species such as ducks and geese may show few clinical signs2.
How is the disease spread?Wild bird species are the natural host and reservoir for all types of avian influenza, naturally carrying the virus in their respiratory and intestinal tracts, commonly without developing signs of the disease1,3. The virus is predominantly spread via body secretions, both directly and indirectly2. Migratory birds (predominantly waterfowl and gulls) can spread the disease over a wide geographical area3.
Why is the winter a higher risk period for avian influenza? The UK is at increased risk of avian influenza from migrating birds during winter2. Furthermore, avian influenza viruses are able to survive for prolonged periods of time in the environment, particularly in low temperatures4.
How can I prevent my birds from contracting avian influenza?All keepers of poultry should ensure that they uphold good levels of biosecurity to prevent disease entering their flock. This includes:
maintaining good levels of hygiene and regularly disinfecting hard surfaces;
changing shoes before entering/leaving to avoid transferring faeces in/out of the poultry enclosure;
minimizing contact with wildlife by humanely controlling rodents and deterring wild birds. Contact with wild birds can be minimized by placing food and water in an enclosed area such as the coop, and preventing poultry from accessing ponds/standing water frequented by wild bird populations, for example by erecting temporary fencing;
where possible, keeping birds of different poultry species separate (e.g. ducks and geese should be separate from chickens).
Whilst it is important that all backyard keepers maintain good levels of biosecurity, it is particularly prudent for keepers in areas deemed at higher risk of an incursion of avian influenza. In Great Britain, a number of High Risk Areas (HRAs) have been identified based upon previous experience, scientific expertise and veterinary opinion, and are predominantly areas where large numbers of migratory wild birds gather. To find out whether you are in a HRA, use the interactive map.
What should I do if I suspect avian influenza?Avian influenza is a notifiable disease. If it is suspected, it must be reported immediately:
In England, contact the Defra Rural Services Helpline on 03000 200 301
In Wales, contact your local Animal and Plant Health Agency (APHA) office on 0300 303 8268
In Scotland, contact your local Field Services Office
For keepers in Northern Ireland, contact your local DVO.
The RCVS has announced the results of the 2013 Council and Veterinary Nurses Council elections.
4,661 veterinary surgeons voted, the highest turnout seen in ten years. 1,329 veterinary nurses voted, the highest ever number.
Veterinary surgeons voted incumbents Christopher Gray, Peter Jinman, Bradley Viner, Christopher Tufnell, and Jeremy Davies back onto the RCVS Council. However, the highest number of votes was given to Thomas Witte, who will be new to Council when he takes his seat in July. Veterinary nurses voted similarly by returning Andrea Jeffery to VN Council, whilst giving to Amy Robinson, another newcomer, the largest number of votes.
According to the College, turnout in both elections has increased markedly on last year in both absolute and proportional terms. Votes were cast by 4,661 veterinary surgeons (18.8%) and 1,329 veterinary nurses (12.5%), compared to 3,625 (15.1%) and 743 (7.5%), respectively, in 2012.
Gordon Hockey, RCVS Registrar said: "We're delighted with the increase in turnout. It's difficult to pinpoint the reasons for the increase, but hopefully, it's because increasing numbers of vets and nurses are feeling more engaged with the College. We have also undertaken extra communications activities this year, such as the 'hustings', which we hope have helped."
The Council election 'hustings' was a new venture this year, with RCVS Council candidates able to select three questions, submitted by voters, to answer in a live webinar run by The Webinar Vet.
Veterinary surgeons and VNs could cast their votes by post, online, or by text. The majority of vets voting chose to cast postal votes (3,247), as did the majority of VNs (1,055). Whilst voting online was used by 1,330 veterinary surgeons, only 227 VNs chose it as a means of voting. Voting by text was used by only 84 veterinary surgeons and 47 VNs.
The successful candidates will take up or resume their seats at RCVS Day on 5 July.
The full results of the two elections are as follows:
RCVS Council electionWITTE, Thomas Hermann - 2,251 (Elected)GRAY, Christopher John - 1,974 (Elected)JINMAN, Peter Charles - 1,949 (Elected)VINER, Bradley Phillip - 1,927 (Elected)TUFNELL, Christopher Wynne - 1,883 (Elected)DAVIES, Jeremy Vincent - 1,830 (Elected)STURGESS, Christopher Paul - 1,809 CONNELL, Niall Thomas - 1,596 ROBINSON, Peter Bayley - 1,366 ELLIS, Robert Nigel Ward - 1,302 GRANT, Lewis George - 832 TORGERSON, Paul Robert - 824 LONSDALE, Thomas - 337 Twenty-two votes in the RCVS Council election were found to be invalid.VN Council election
ROBINSON, Amy - 725 (Elected)JEFFERY, Andrea Karen - 607 (Elected)BADGER, Susan Frances - 459TOTTEY, Helen Wendy 332 One vote in the VN Council election was found to be invalid.The 2013 RCVS and VN Council elections were run on behalf of the RCVS by Electoral Reform Services.
Time spent discussing the articles can be claimed towards the annual CPD requirement by pressing the ‘Claim CPD’ link at the top of the forum discussion thread.
The first article up for discussion is “What diet should we feed a cat or dog with cancer?”, by Owen Davies, who will be joining us in the forum.
Owen is an RCVS, American and European Specialist in Veterinary Oncology working at Highcroft Referrals.
He graduated from Cambridge in 2005, worked in rural practice for three years, followed by a spell working for charities and then at a large hospital.
In 2014, he moved to the RVC to specialise in oncology before joining Highcroft in 2017.
VetSurgeon.org Clinical Editor, Alasdair Hotston Moore said: “For general practitioners, I think this adds a really valuable extra dimension to your clinical reading.
“It’s not just the opportunity to ask questions of the author, but also to discuss the implications and practicalities of the article amongst yourselves.
VetSurgeon.org Editor, Arlo Guthrie added: “More than that, it’s also in a closed professional community where you can be 100% confident of a friendly atmosphere and authoritative opinions with provenance.
“And more even than that, the questions you ask and the discussion you have are then available as a useful, searchable resource for everyone in the profession.”
So do come and join in.
First read the article here: https://www.veterinary-practice.com/article/what-diet-should-we-feed-a-cat-or-dog-with-cancer
Then come and join the discussion here: https://www.vetsurgeon.org/001/veterinary-clinical/small-animal/f/misc-case-discussions/30507/new-clinical-article-club-what-diet-should-we-feed-a-cat-or-dog-with-cancer-with-owen-davies
Mark Morton is an RCVS Specialist in small animal orthopaedics, with a particular interest in cruciate ligament injuries: he developed the RCVS Knowledge ‘Canine Cruciate Registry’, of which he remains clinical lead.
Mark has published peer-reviewed papers in the areas of Achilles tendon injury and clinical outcomes measures, as well as pioneering a novel technique to repair Achilles tendon injuries which is now used internationally.
Prior to joining Movement Referrals, Mark has been the lead clinician at a multi-disciplinary referral centre for the last 3 years.
The other Mark, Lowrie, is RCVS and EBVS European Specialist in Veterinary Neurology.
Mark is a global leader in movement disorders in dogs, and has over 50 peer-reviewed articles to his name.
He has also established novel treatment strategies for meningoencephalitis, a common, disabling brain condition of dogs, which has reduced mortality by over 50%.
Mark Morton (pictured) said: “I am delighted to be joining the management team at Movement Referrals.
"I know the rest of the team very well having worked closely with them all before, I can’t think of a better or more experienced team to develop this practice with.
"We aim to provide exceptional care to our patients, with a real focus on the service we provide and the outcomes we achieve”
The two Marks will join the Board of Directors with Ben Walton and Professor John Innes, both RCVS Specialists, and Dr Brian Beale, an ACVS-boarded Specialist in small animal surgery.
Bayer has announced that it has launched a new bone-shaped version of the Drontal Plus tablet with greatly increased palatability to increase client compliance.
In a field study, new Drontal Dog Tasty Bone proved to be voluntarily consumed by 88% of 150 dogs1.
Vicky McAlister, Group Product Manager at Bayer said: "We want to make it as easy as possible for responsible dog owners to remember to worm their pet at least every three months. To help improve compliance, there is an increased necessity for highly palatable oral dosage forms. To meet this need, the Drontal Plus Tasty tablet has been optimised using a novel formula that has an extremely high level of palatability where the majority of dogs take the tablet straight out of the owners hand like a treat - proving that Drontal is now tasty by nature as well as name!
This combined with the memorable bone-shaped design will help cement Drontal as the wormer of choice in the minds of owners."
Is it just me, or does the name of this product sound a bit like someone who has ingested a series of words, and then regurgitated them in no particular order? I suppose Drontal Tasty Dog Bone means something else, and Tasty Dog Drontal Bone doesn't really work.
Porus One contains renaltec, a selective absorber that absorbs the precursors of uraemic toxins in the cat’s intestine that would normally be removed or regulated by healthy kidneys, so that they may be safely excreted in the cat's faeces.
The product is presented as a powder which can be sprinkled on wet cat food, or given with Add One as a treat.
Dechra says it is well-accepted by cats due to its neutral taste and smell.
Add One is a moist and tasty cat treat developed to encourage cats that prefer dry food to eat Porus One.
It is available in two flavours: creamy salmon and tasty liver.
Add One contains omega-3 and a high moisture content to help support kidney health.
It also contains taurine to support a cat’s eyes and heart.
One box of Porus One contains 30 single-dose sachets, each containing 500mg of renaltec.
One box of Add One contains 30 single-dose 10mg sachets.
https://porus-one.com.
Dechra Veterinary Products has relaunched Oxyglobin after concluding an exclusive agreement to supply the product across the UK and Republic of Ireland.
Oxyglobin is used to stabilise anaemic dogs until the underlying condition can be controlled and the animal's body can produce its own new red blood cells.
Dechra says the treatment, which is now available in both 125ml bags and individual 60ml transfusion bags, maintains tissue oxygenation even when there is severe stenosis of blood vessels. It has a viscosity which is more than water but less than blood for ease of flow through vessels, and also increases circulatory volume.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Veterinary professionals have been waiting for Oxyglobin to come back onto the market for some time and we're delighted to be able to relaunch it in the UK and Republic of Ireland.
"It was withdrawn from the market in 2010 when OPK Biotech acquired the assets of manufacturer Biopure Corporation in 2009. But this year, OPK Biotech resumed the manufacture of Oxyglobin and we have stocks available to practices from this month (FEB)."
"Oxyglobin turns around clinical outcomes for dogs with anaemia, regardless of the cause of the condition, which is why it is the objective choice for safety, effectiveness and convenience.
"Oxyglobin is the only oxygen-carrying fluid available off the shelf for dogs in need of oxygen support and no typing or cross-matching of the recipient's blood is required."
Oxyglobin, a sterile formulation of polymerised purified bovine haemoglobin in a balanced salt solution with proven efficacy, is available in single dose 60ml and 125ml infusion bags.
For further information on Oxyglobin, see www.dechra.co.uk
This, says the government, would be one of the toughest sanctions in Europe, strengthening the country's claim to be a global leader on animal welfare.
The Animal Welfare (Sentencing) Bill comes after a public consultation held last year which found that more than 70% of people supported proposals for tougher prison sentences. It will allow the courts to take a tougher stance on things like dog fighting, puppy and kitten abuse, and neglect of farm animals.
The new Bill has been welcomed by animal welfare charities.
Chief Executive for the RSPCA, Chris Sherwood, said: "This reform is long overdue. Those responsible for extreme cruelty towards animals or those criminal gangs involved in organised animal crime will now face the tough justice they deserve.
"We need to better protect our animals and the RSPCA hopes that this new Animal Welfare (Sentencing) Bill will give courts the powers they need to punish those responsible for the most unimaginable cruelty to animals.
"We also believe this will act as a much stronger deterrent to others and help us stamp out animal cruelty once and for all."
James Yeates, Cats Protection’s Chief Executive said: "We very much welcome this announcement which is an important step in ensuring the UK is one of the world leaders on animal welfare issues.
Claire Horton, Chief Executive of Battersea Dogs & Cats Home, said: "The introduction of this bill is a landmark achievement, which will make a profound difference to dogs and cats in England and Wales."
The latest figures from 2017/18 reveal that over 120 million animals were slaughtered in England and Wales without being stunned first1.
In an open letter to Environment Secretary Michael Gove, the BVA and the RSPCA urge the UK Government to change legislation in England which currently allows non-stun slaughter for religious purposes, and provide further public transparency on this issue by releasing the comprehensive 2018 slaughter survey results, which Mr Gove himself signalled would be published by Autumn 2018.
Until such legislation is in place the RSPCA and BVA are calling for:
meat to be labelled with the method of slaughter, e.g. stunned or non-stunned, so consumers are fully informed about the meat that they are buying.
non-stun slaughter to only be permitted at levels that meet local religious community demand for this type of meat in the interests of limiting animal pain and suffering.
a ban on export of meat from non-stunned animals or live animals destined for non-stun slaughter.
an immediate post-cut stun for cattle, sheep, goats and deer to reduce the period of pain and distress.
The letter follows a recent, high profile decision to ban the slaughter of animals without prior stunning in the Flanders region of Belgium which came into force at the start of the year. Belgium joins several other European countries, including Iceland, Sweden, Switzerland and Denmark in making this decision, demonstrating that a full ban on non-stun slaughter is possible within EU law.
RSPCA chief executive, Chris Sherwood said: "Until there is a change in the law to end non-stun slaughter, there are several measures the UK Government could introduce to reduce the suffering involved in this practice. For example, by ensuring trade deals with other countries do not include non-stun meat or live animals for non-stun slaughter, clear labelling should be adopted to enable consumers to make an informed choice about the meat they buy and how it was slaughtered."
BVA President Simon Doherty said: "The UK Government has repeatedly stated it would prefer to see all animals stunned before slaughter but has taken no action to address this critical welfare issue that affects millions of animals every year. It is doubly disappointing that data that would have provided a valuable benchmark for levels of non-stun slaughter in the UK has yet to see the light of day despite assurances throughout last year that it would soon be made public.
"There is a huge groundswell of support for a ban on non-stun slaughter, and recent developments in Belgium show that decisive change is possible where public support is matched by political will. Michael Gove has made clear that he wants to maintain and build on the UK’s reputation as global leader on animal welfare; banning non-stun slaughter is a surefire way of showing he will deliver on this commitment.
"If slaughter without stunning continues to be permitted in the UK, then meat and fish from this source must be clearly labelled, to help customers make informed choices about the food that they buy and eat."
You can sign the open letter at: www.rspca.org.uk/endnonstun and join the online debate using the hashtag #EndNonStun.
The procedure was performed in Canada through an international collaboration between partners from Germany, Canada and the UK, who say that this was a case where the placement of the tumour made it impossible to operate without severely impacting the dog’s quality of life. The most suitable treatment was a total excision of the growth and reconstruction with an implant.
The implant was designed with medical CAD tools by German company, Voxelmed, using 3D imaging from the affected area. The dog's veterinary surgeon, Julius Liptak, contributed to the design to ensure it met specifications and allowing him to plan the procedure in advance.
UK company Renishaw then additively manufactured the patient specific implant (PSI) at the Additive Design In Surgical Solutions (ADEISS) Centre in London, Ontario, Canada.
Ed Littlewood, Marketing Manager at Renishaw’s Medical and Dental Products Division said: "Without the advancements in additive manufacturing technology, this dog would not have had such a long and happy future ahead of him.
"Prior to this case, many veterinary surgeons were unaware that the technology was available. Similar procedures are now being planned in Germany and further research is underway to see how animals can benefit from additively manufactured PSIs.
Jan Klasen, veterinary surgeon, 3D designer and CEO of Voxelmed said: "Without AM technology, it would have been almost impossible to reconstruct the dog’s maxilla after tumour removal, because the area was extremely complex in geometry. The implant had to have a similar shape and functionality as the dog’s existing bone structure.
"Using additive manufacturing to maintain the original shape and function of the oral and nasal cavity ensures a high quality of life for the dog, just as a naturally shaped skull and maxilla helps the dog to breathe and eat easily."
To read the full case study, visit http://www.renishaw.com/en/additive-manufacturing-in-veterinary-surgery-saving-a-well-loved-member-of-the-family--42950.
A sign up section where Official Veterinarians (OVs) can register to continue providing bTB testing with aspiring Delivery Partner Xperior Farm Health under AHVLA's Veterinary Delivery Partnership programme has been added to Xperior's website (www.xperiorfarmhealth.co.uk/vets/).
Xperior Farm Health is the joint venture between Eville & Jones and Westpoint Veterinary Group that is one of the declared bidders for appointment by AHVLA as a Delivery Partner. Veterinary Director Phil Elkins said: "If appointed, we are fully committed to maintaining sub-contractor OV involvement."
As alternatives to website sign up, OVs can also do so by email (phil.elkins@xperiorfarmhealth.co.uk) or post using either a printed form that was mailed recently to more than 1,000 farm vets or by writing to Mr Elkins at Century House, Thorpe Park, Leeds LS15 8ZB.
To give experienced OVs an opportunity to influence the Delivery Partner bid, Xperior have also extended their online survey (https://www.surveymonkey.com/s/PQFSWZN) until the end of July.
Phil added: "If appointed, our commitment is to provide an exemplary standard of accurate and trustworthy on-farm animal health testing services, where possible using subcontracted practices. These will be farmer friendly, provide an ongoing source of work and revenue to subcontractor Official Veterinarians, and represent excellent value for money to the taxpayer."